Dow Up1.30% Nasdaq Up0.37%

GlaxoSmithKline plc (GSK)

-NYSE
45.14 Up 0.06(0.13%) Oct 30, 4:06PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 43,899,000   42,964,000   42,563,000  
Cost of Revenue14,219,000  12,882,000  11,925,000  
Gross Profit 29,680,000   30,082,000   30,638,000  
Operating Expenses
Research Development6,498,000  6,468,000  6,248,000  
Selling General and Administrative11,542,000  11,748,000  12,371,000  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss 11,640,000   11,866,000   12,020,000  
Income from Continuing Operations
Total Other Income/Expenses Net568,000  128,000  1,049,000  
Earnings Before Interest And Taxes12,279,000  12,041,000  13,092,000  
Interest Expense1,270,000  1,313,000  1,242,000  
Income Before Tax11,009,000  10,728,000  11,850,000  
Income Tax Expense1,688,000  3,124,000  3,450,000  
Minority Interest(318,000)(291,000)(306,000)
Net Income From Continuing Ops9,075,000  7,360,000  8,117,000  
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income 9,003,000   7,313,000   8,094,000  
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares 9,003,000   7,313,000   8,094,000  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.